Jim Simons Heart Test Laboratories, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.83 - $1.26 $10,499 - $15,939
12,650 Added 55.73%
35,350 $32,000
Q1 2023

May 12, 2023
SELL
$0.78 - $3.4 $156 - $680
-200 Reduced 0.87%
22,700 $22,000
Q4 2022

Feb 13, 2023
BUY
$0.8 - $267.0 $5,840 - $1.95 Million
7,300 Added 46.79%
22,900 $19,000
Q3 2022

Nov 14, 2022
BUY
$1.15 - $126.0 $17,940 - $1.97 Million
15,600 New
15,600 $18,000

About Heart Test Laboratories, Inc.

HSCS Quotes by TradingView
  • Ticker HSCS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,202,550
  • Market Cap $21.9M
  • Description
  • Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...
More about HSCS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email